Formycon Joins the SDAX of the German Stock Exchange

Formycon AG is set to join the SDAX of the German Stock Exchange, marking a significant step in the company's market presence. As of December 23, 2024, Formycon's shares will be part of the index family that includes the 70 largest German companies below the MDAX. This follows its recent uplisting to the Prime Standard, enhancing the appeal of its shares.

Enno Spillner, CFO of Formycon AG, stated that joining the SDAX is a crucial milestone, enhancing Formycon's market visibility and supporting its growth strategy as a leading biosimilar developer. This inclusion is a recognition of Formycon's successful capital market strategy and solid team efforts.

Formycon's journey from its debut on the Open Market in 2010 to its current status illustrates its commitment to meeting market demands, paving the way for robust business growth.